Income from Continuous Operations: A company's total income or loss before discontinued operations, extraordinary items, preferred stock dividends and accounting change.
Anthera Pharmaceuticals, Inc. (ANTH) had Income from Continuous Operations of $-7.72M for the most recently reported fiscal quarter, ending 2018-03-31.
| Income Statement Financials | |
-- |
|
$-9.26M |
|
-- |
|
-- |
|
$10.97M |
|
$-10.97M |
|
$3.25M |
|
$-7.72M |
|
$-7.72M |
|
$-7.72M |
|
|
Income from Continuous Operations |
$-7.72M |
$-7.72M |
|
$-7.72M |
|
$-10.97M |
|
$-10.81M |
|
22.17M |
|
22.17M |
|
$-0.42 |
|
$-0.42 |
|
| Balance Sheet Financials | |
$8.74M |
|
$0.07M |
|
$0.07M |
|
$8.81M |
|
$2.65M |
|
-- |
|
$0.70M |
|
$3.35M |
|
$5.46M |
|
$5.46M |
|
$5.46M |
|
26.18M |
|
| Cash Flow Statement Financials | |
$-9.38M |
|
$0.36M |
|
$14.91M |
|
$2.20M |
|
$8.09M |
|
$5.89M |
|
$3.30M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.30 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-9.02M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-141.44% |
|
-141.44% |
|
-87.66% |
|
-141.44% |
|
$0.21 |
|
$-0.41 |
|
$-0.42 |
|